Werewolf Therapeutics, Inc. announced the appointment of Ellen Lubman to the company's newly created position of Chief Business Officer. In this role, Ms. Lubman will oversee corporate and business development, portfolio strategic planning, financial strategy and investor relations. Ms. Lubman brings vast biopharmaceutical industry experience to the Werewolf Therapeutics team. She joins Werewolf from Impel NeuroPharma, where she was Chief Business Officer.